According to the peer evaluations at the Longevity Clinic Roundtable, the 2026 awards recognized the leadership of Fountain Life in data-driven longevity medicine. The company stated that this model is based on over 15 billion clinical data points and measurable member outcomes.
Orlando, Florida, USA, October 21st / PRNewswire / -- Fountain Life is an award-winning longevity and health institution that focuses on driving medical transformation through early disease detection, precise diagnosis, and optimization of healthy lifespan. The Longevity Clinic Roundtable has named it the Longevity Clinic of the Year for 2026, marking the second consecutive year the company has received this award.
The award is determined by votes from leaders and experts in the field of longevity medicine, and is intended to recognize the work of Fountain Life in transforming longevity science into proactive, personalized care. The award ceremony was held alongside a roundtable conference at the Buck Institute for Aging in Novato, California.
The Chief Medical Officer, Dawn Mussallem, Ph.D., stated: "Receiving this award on behalf of Fountain Life is a moment of great pride. Being recognized as the Longevity Clinic of the Year for the second consecutive year by our peers is a strong acknowledgment of our team's dedication to advancing precision medicine." She added, "Most importantly, it reflects the purpose of our work: to help our members live longer, healthier, and more fulfilling lives."
Promote Proactive Healthcare
The Fountain Life model combines advanced diagnostics, continuous health tracking, and personalized interventions to help doctors identify risks earlier and measure changes in health status over time.
Mussallem said, "The uniqueness of Fountain Life lies in its ability to go beyond one-time diagnostic tests, to continuously measure health status, to identify diseases earlier, and to assess the effectiveness of personalized interventions over time."
The company's longitudinal dataset contains over 15 billion clinical data points from more than 8,000 members. Its findings include:
- Cardiovascular Health: 88% of members showed early signs of coronary artery plaques; 26% of members experienced a halt in plaque progression, and 6% of members saw plaque reversal.
- Metabolic Health: 51% of pre-diabetic members returned to normal blood sugar levels after an average of 1.2 years; 64% of diabetic members improved to a healthier metabolic range.
- Liver Health: Subsequently, MRI confirmed that 52% of fatty liver cases were alleviated.
- Brain Health: Nearly a quarter of the members showed accelerated brain aging at baseline; 46% of the members showed improvement in subsequent measurements.
- Cancer Detection: Early cancer signals were identified in up to 3.4% of members.
Transform data into personalized care
The membership services of Fountain Life combine AI guided diagnostics, Zori AI medical expertise, restorative treatments, and 24/7 care. Testing options can include full-body and brain MRI examinations, coronary artery plaque analysis, whole-genome sequencing, biological age analysis, over 100 blood biomarkers, microbiome analysis, VO tests, as well as functional exercise assessments. Other optional services include early detection for multiple cancers, neurocognitive testing, and assessments for nutrition, mitochondria, environmental toxins, and immune longevity.
These technologies can generate more than 150GB of health data for each member in total. Zori AI helps doctors to correlate the results of different diagnostic methods and develop health optimization plans. Members can also receive guidance led by doctors, continuous monitoring, as well as support from a dedicated nursing team and advanced treatment methods.
Expansion across the United States
Fountain Life currently has centers in New York, Naples, Orlando, Dallas, and Houston, and plans to open new locations in Los Angeles and Miami.
About Fountain Life
Fountain Life is a leading longevity brand dedicated to helping people not only live longer but also live better. By combining cutting-edge science with advanced AI guided diagnostics and restorative therapies, Fountain Life offers the next generation of preventive healthcare models. This model integrates regenerative medicine with AI driven health intelligence to enable early detection of diseases, optimize performance, and extend healthy lifespan.
Fountain Life was founded in 2020 by pioneers in the fields of business, medicine, and innovation: Dr. Peter Diamandis, Dr. Tony Robbins, Dr. Robert Hariri, and Dr. William Kapp. Its mission is to fill a critical gap in healthcare: the lack of proactive, data-driven care that emphasizes prevention, optimization, and the extension of healthy lifespan and life expectancy.
In 2025 and 2026, Fountain Life was recognized as the Annual Longevity Brand, highlighting its leading position in high-end preventive healthcare and health lifespan optimization. In the same years, Fountain Life's proprietary intelligent engine, Zori AI, also won a Global Technology Award for its breakthrough role in driving health intelligence and personalized longevity guidance through AI.
Through tiered membership programs CORE, APEX and APEX FAMILY, Fountain Life provides scalable services for this innovative model. At its core is Zori AI, which integrates the comprehensive health data of each member to identify hidden risks and offer highly personalized recommendations.
These insights are implemented by a dedicated care team and on-demand virtual medical services to ensure continuous support and precise delivery. Fountain Life is redefining the future of medicine, and this service is already available. For more information or to take control of your own health, please visit www.fountainlife.com.
